Oculis Holding AG Amended Loan Facility Agreement

SEC Filing 6-K (0001193125-25-171649)

Oculis Holding AG entered into an amended and restated loan facility agreement with Kreos Capital VII (UK) Limited on July 31, 2025. The agreement provides a borrowing capacity of up to CHF 75.0 million, which can be increased to CHF 100.0 million. The loan is structured into three tranches of CHF 25.0 million each, with an additional CHF 25.0 million available upon mutual agreement. The loan has specific drawdown periods and conditions, including a debt-to-market cap ratio requirement. Interest rates are fixed at 9.7%, 9.6%, and 9.5% per annum for the respective tranches. The loan includes an interest-only period and maturity dates that can be adjusted based on certain conditions. The agreement also involves an amended warrant allowing the purchase of up to 494,259 ordinary shares at specified prices. The proceeds from the loan will be used for general corporate purposes.